Joshua Schafer - Aug 29, 2022 Form 3 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Role
Director
Signature
/s/ Joshua Schafer
Stock symbol
SHPH
Transactions as of
Aug 29, 2022
Transactions value $
$0
Form type
3
Date filed
9/7/2022, 09:19 AM
Next filing
Jan 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SHPH COMMON STOCK 2.7K Aug 29, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The undersigned became a Reporting Person subject to Section 16 reporting on August 29, 2022 at the time Shuttle Pharmaceuticals Holdings, Inc ("Company") completed its initial public offering ("IPO"). At the time of the IPO, the Reporting Person was the beneficial owner of 2,702 shares of common stock of the Company, consisting of 2,702 restricted stock units, all of which have fully vested.